Skip to main content
English
中文
Log In
Email address
Password
Log in
Log in with ORCID
NTU Single Sign On
New user? Click here to register.
Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
People
Organizations
Statistics
Home
.National Taiwan University / 國立臺灣大學
Project / 研究計畫
Anti-Pancreatic Cancer Drug Development Based on Enhancing FasL-Induced Apoptosis and Evaluation Mechanisms and Combined Benefits with Chemotherapy Agents/Radiation Treatment
Export
Statistics
Options
Show all metadata (technical view)
Anti-Pancreatic Cancer Drug Development Based on Enhancing FasL-Induced Apoptosis and Evaluation Mechanisms and Combined Benefits with Chemotherapy Agents/Radiation Treatment
Details
Primary Data
Project title
以增進FasL引起的細胞凋亡為考量的抗胰臟癌天然藥物研發並評估與化療藥物/放射線療法合併之應用及機轉探討
Internal ID
NSC97-2320-B002-019-MY3
Principal Investigator
CHIA-RON YANG
Start Date
August 1, 2009
End Date
July 31, 2010
Organizations
Pharmacy
Partner Organizations
National Science and Technology Council
